Page 23 - ARNM-2-1
P. 23

Advances in Radiotherapy
            & Nuclear Medicine                                             Is 5-mm PTV margin 4D-CT-based radiotherapy



            1. Introduction                                    with locally advanced lung cancer between helical FBCT
                                                               and 4D-CT. In addition, we assessed the feasibility of
            Lung cancer ranks as the second most common cancer with   achieving a lower PTV margin with 4D-CT planning.
            an incidence of 11.6% and carries the highest mortality
            rate at 18.4%.  Radiotherapy is a common component of   2. Methods
                       1
            the multimodal management of lung cancer. The most
            common course of treatment for locally advanced or stage   2.1. Participants
            III non-small cell lung cancers (NSCLCs) is concurrent   This prospective, non-randomized cohort study was
            chemoradiotherapy or radical radiotherapy alone.    conducted at a tertiary cancer care center in Eastern
                                                         2,3
            Similarly, patients with limited-stage small-cell lung cancer   India between January 2021 and March 2023. Ethical
            and certain stage IV NSCLC patients with oligometastatic   approval for this study was obtained from the Institutional
            disease  are  also  treated  with  radical  radiotherapy.  For   Ethics  Committee  of  Apollo  Multi-Speciality  Hospital,
            patients with early-stage NSCLC (stages I and II) who are   Kolkata (approval no.: IEC/2021/DNB/04/17). The
            not suitable candidates for surgery or stereotactic adjuvant   inclusion criteria were as follows (i) Age: 18 – 70 years
            radiotherapy (SABR), radiotherapy alone or combined   old; (ii) biopsy-proven lung cancer (NSCLC or SCLC);
            with other multimodality management strategies can be   (iii) locally advanced NSCLC (stage III); (iv) early-stage
            employed.  However, a significant percentage of lung   NSCLC (stages I and II) who are not suitable for surgery
                    4-6
            cancer patients experience locoregional recurrence after   or SABR; (v) limited stage small cell lung cancer; and
            treatment with radiotherapy or chemo-radiotherapy.    (vi) patients receiving a radiotherapy dose of 60 – 66 Gy in
                                                         1,7
            Although the reason for such recurrence is multifactorial,   30 – 33 fractions over 6 – 6.6 weeks, possessing adequate
            geographical misses and suboptimal doses of gross   lung function to undergo definitive radiotherapy, and
            disease  secondary  to  tumor  motion  play a  pivotal  role.   willingness  to  provide  consent  for  participation  in  the
            Conventionally, helical free-breathing CT scans (FBCT)   study. The exclusion criteria were as follows (i) patients not
            have been the standard for lung radiotherapy treatment   willing to provide consent; (ii) patients unable to cooperate
            planning for many years.                           during  4D-CT  scanning;  and (iii)  patients  receiving

              In general, a population-based safety margin is used   palliative radiotherapy.
            around both gross disease (gross tumor volume [GTV])   2.2. Helical FBCT and 4D-CT procedure
            and microscopic disease (clinical target volume [CTV]) to
            determine the final radiotherapy planning target volume   Helical FBCT and 4D-CT planning scans were derived
            (PTV).  However, lung tumors can move erratically during   during the same session with the patient in the  same
                 8
            respiration in an unpredictable manner. The inability   treatment position. The standard institutional protocol was
            to encompass the range of tumor motion might lead to   adhered to for FBCT imaging. The patient’s breathing cycle
            inadequate tumor coverage, and using larger generalized   was monitored for 4D-CT image capture using either the
            population-based margins can cause unnecessary toxicity   real-time position management system (Varian Medical
            to nearby organs at risk (OARs). 9-11   4D-Computed   Systems Inc., USA) or the Philips bellows device (Philips
            tomography (4D-CT) has shown promising results in   Healthcare, USA), employing infrared reflector markers
                                                                                 10,16
            mitigating motion management issues associated with   and infrared cameras.   The GTV_3D was contoured
            radiotherapy in lung cancer. 4D-CT scans have become   on an FBCT scan using fluorodeoxyglucose positron
                                   12
            the standard to derive detailed information regarding the   emission tomography (PET) image fusion to identify
            pattern and range of respiratory motion.  Since tumor   primary and/or nodal illness. The number of nodes and
                                              13
            motion is inherently considered when using 4D-CT scans,   mediastinal disease were contoured on the mediastinal
            a smaller safety margin for set-up error (PTV) can be   window,  whereas  parenchymal  tumors  were  contoured
            used during lung radiotherapy planning.  In 76% of the   at the lung window level. The CTV_3D was created by
                                             14
            treatment fractions, Steiner et al. demonstrated that a 5-mm   expanding the GTV_3D by 5 mm in all directions and
            PTV margin was sufficient to capture the 4D-CT-based   then modifying it to remove natural barriers, such as air
            motion data, with brief intervals of excess motion (varying   and bone. To account for internal margin and setup faults,
            from 1% to 20% of the treatment period).  However, there   the PTV_3D was calculated as CTV_3D + 1 cm axial and
                                             15
            is a risk of geographical miss with a very small PTV margin   1.3 cm superior/inferior expansions. Organs at risk were
            when setting up 4D-CT-based image-guided radiotherapy   contoured according to the standard Radiation Therapy
                                                                                                      17
            (IGRT) for lung cancer. In this study, we aimed to compare   Oncology Group (RTOG) contouring guidelines.
            the dosimetric and volumetric differences in target volume   A fusion of PET-CT was used for 4D-CT-based
            delineation for radical radiotherapy planning in patients   contouring whenever available, although it was not


            Volume 2 Issue 1 (2024)                         2                       https://doi.org/10.36922/arnm.2784
   18   19   20   21   22   23   24   25   26   27   28